Log in to save to my catalogue
Log in to save to my catalogue

Correction: Cost-Effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age-Related Macula...

| Ask | Become a Library member

Correction: Cost-Effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age-Related Macula...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_69898440c1b84610abdd8d9fb5086f10

Correction: Cost-Effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age-Related Macular Degeneration in Japan

About this item

Full title

Correction: Cost-Effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age-Related Macular Degeneration in Japan

Author / Creator

Yanagi, Yasuo , Takahashi, Kanji , Iida, Tomohiro , Gomi, Fumi , Morii, Junko , Kunikane, Eriko and Sakamoto, Taiji

Publisher

Cheshire: Springer Healthcare

Journal title

Ophthalmology and Therapy, 2023-10, Vol.12 (5), p.2821-2822

Language

English

Formats

Articles

Publication information

Publisher

Cheshire: Springer Healthcare

Subjects

More information

Alternative Titles

Full title

Correction: Cost-Effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age-Related Macular Degeneration in Japan

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_69898440c1b84610abdd8d9fb5086f10

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_69898440c1b84610abdd8d9fb5086f10

Other Identifiers

ISSN

2193-8245

E-ISSN

2193-6528

DOI

10.1007/s40123-023-00788-9

How to access this item

Log in as a Library member

Full text available

About resource

View in old catalogue

Connecting people and collections